SMS Pharmaceuticals Ltd shares receive credit rating update as agency intimates revised rating
Why did SMS Pharmaceuticals Ltd shares jump today?
SMS Pharmaceuticals Ltd shares rose by 0.89% on Wednesday, trading at ₹370.35 as of 10:34 AM. This uptick in the share price is directly linked to a positive development announced by the company in a regulatory filing. The stock market responded favorably to news regarding the company's creditworthiness.
The update came from CARE Ratings Limited, which reaffirmed the company's credit rating for its bank facilities. Specifically, the long-term bank facilities, now enhanced to ₹507.07 crore, were reaffirmed with a 'CARE A' rating. Furthermore, the outlook for this rating was revised from Positive to Stable. The short-term bank facilities, totaling ₹52.83 crore, were also reaffirmed with a 'CARE A1' rating. This steady and reaffirmed assessment from a credit rating agency signals financial stability and reduced risk for lenders, which is viewed as a positive indicator by investors.
This kind of credit rating intimation, made under SEBI regulations, provides transparency to the market about the company's financial health. A reaffirmation of a solid rating, especially on enhanced credit limits, suggests the company has access to necessary capital for its operations and growth plans without a significant deterioration in its credit risk profile. This reassurance likely contributed to the positive sentiment and the share price movement observed this morning.
What does SMS Pharmaceuticals Ltd do?
SMS Pharmaceuticals Ltd is a publicly listed company on Indian stock exchanges, specifically the BSE and National Stock Exchange of India. The company operates with bank facilities, as it maintains long-term and short-term banking arrangements that are subject to evaluation and rating by financial institutions.
The company engages in formal corporate governance and disclosure practices, as evidenced by its regular communication with stock exchanges regarding material information such as credit rating updates. Its financial activities are substantial enough to require the evaluation of credit ratings from agencies like CARE Ratings Limited.
SMS Pharmaceuticals Ltd Financials
In CroresSMS Pharmaceuticals Ltd reported a revenue of ₹237.95 Crores for the quarter ended March 2026, which declined to ₹206.96 Crores by June 2026. Correspondingly, the company's profit stood at ₹32.71 Crores in March 2026 and decreased to ₹20.91 Crores in June 2026. Both metrics indicate a quarter-on-quarter downward trend, reflecting a contraction in both top-line and bottom-line performance.
SMS Pharmaceuticals Ltd Shareholding Pattern
Promoter holding stands at 68.07% of the total share capital. Foreign Institutional Investors (FIIs) hold 0.65% stake in the company, while Domestic Institutional Investors (DIIs) hold 2.83%. Public shareholders hold the remaining 28.45% stake in SMS Pharmaceuticals Ltd.
SMS Pharmaceuticals Ltd FAQs
Q: Why did SMS shares jump 0.89% today?
Credit Rating Intimation. This corporate action caught investor attention, leading to increased trading activity in the stock.
Q: What is the shareholding pattern of SMS Pharmaceuticals Ltd?
As per the latest data, promoters hold 68.07% stake in SMS Pharmaceuticals Ltd, while FII holding stands at 0.65%. Domestic institutional investors hold 2.83%, and public shareholders account for 28.45% of the equity.
Q: What is the current stock price of SMS Pharmaceuticals Ltd?
SMS Pharmaceuticals Ltd shares are currently trading at ₹370.35, recording a gain of 0.89% from the previous close.
Q: What is the market capitalization of SMS Pharmaceuticals Ltd?
The company currently has a market capitalization of ₹3468.4 crore, reflecting its valuation in the Indian equity market.